ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SLDX Stella Diagnostics Inc (PK)

0.0633
0.00 (0.00%)
Feb 23 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0.00
Bid Price 0.0433
Ask Price 0.10
News -
Day High

Low
0.027

52 Week Range

High
0.296

Day Low
Company Name Stock Ticker Symbol Market Type
Stella Diagnostics Inc (PK) SLDX OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.0633 07:47:35
Open Price Low Price High Price Close Price Prev Close
0.0633 0.0633
Trades Volume Avg Volume 52 Week Range
0 0.00 - 0.027 - 0.296
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.0633 USD

Stella Diagnostics Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 25.42M 401.60M - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Stella Diagnostics (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SLDX Message Board. Create One! See More Posts on SLDX Message Board See More Message Board Posts

Historical SLDX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.04330.06330.04330.05706151640.0246.19%
3 Months0.0270.100.0270.06219156490.0363134.44%
6 Months0.09920.2960.0270.07706482,398-0.0359-36.19%
1 Year0.100.2960.0270.10952214,748-0.0367-36.70%
3 Years0.721.900.0270.47650165,288-0.6567-91.21%
5 Years0.721.900.0270.47650165,288-0.6567-91.21%

Stella Diagnostics (PK) Description

Stella Diagnostics, Inc. is a molecular diagnostics-based organization focused on improving patient management strategies for over 67 million people living with severe esophageal disease. Stella Diagnostic's mass spec proteomic assays will offer physicians insight into the molecular properties of their patients' tissue to determine if the disease is stable, progressing or turning cancerous. Stella Diagnostics aims to offer a first-line diagnostic tool that provides superior molecular information for providers as compared to the current standard screening protocols.

Your Recent History

Delayed Upgrade Clock